Announcements


30.Apr.25An article by John Richards about the recent decisions of the Court of Appeals of the Federal...

23.Apr.25L&P attorney David Brezina has been appointed to serve as a member of the ISBA Intellectual...

15.Apr.25On May 13, 2025, the U.S. Patent and Trademark Office (USPTO) will expedite Issue Dates for...

08.Apr.25Ladas & Parry attorney John Richards will serve as a moderator and a speaker during the 32nd...

View all Announcements »


ladas-brochure-download

  • This case saw a return to the question of what is meant by 35 USC 112 paragraph 6 which has been troubling the Federal Circuit and practitioners for much of the past...

    Details Share b
  • In re Peterson involved an appeal from the USPTO Board of Appeals with respect to the patentability of the claims of a pending US patent...

    Details Share b
  • This is a complex case involving a non-naturally occurring erythropoietin-glycoprotein product having a defined in vivo biological activity and having glycosylation which differs from that of human urinary...

    Details Share b
  • This was a Paragraph IV certification case filed after Novopharm filed an ANDA to market a generic form of fenofibrate prior to expiration of the relevant...

    Details Share b
  • The invention related to the isolation of the virus that caused “Mystery swine disease” (a.k.a Porcine Reproductive Respiratory Syndrome – PRRS). The claim was directed to growing and isolating a particular virus. The alleged infringement...

    Details Share b